Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Nucl Med Biol. 2013 Mar 23;40(4):498–506. doi: 10.1016/j.nucmedbio.2012.12.013

Table 2.

Biodistribution of [18F]9b in BALB/c mice with subcutaneous DBT tumors. Mice were anesthetized with 1% isoflurane/oxygen and 20–30 μCi (0.74 – 1.1 MBq) of [18F]9b was administered via tail vein injection. The animals were euthanized in groups of 4 animals at 5, 30 and 60 minutes post injection.

5 min 30 min 60 min
blood 4.06 ± 0.35 0.44 ± 0.07 0.15 ± 0.04
bone 1.08 ± 0.11 0.42 ± 0.05 0.30 ± 0.06
brain 0.24 ± 0.08 0.08 ± 0.01 0.04 ± 0.01
fat 1.12 ± 0.32 0.17 ± 0.11 0.09 ± 0.04
heart 2.29 ± 0.16 0.67 ± 0.05 0.27 ± 0.15
kidney 18.09 ± 1.46 2.07 ± 0.37 0.55 ± 0.07
liver 4.12 ± 0.33 0.49 ± 0.04 0.17 ± 0.02
lung 3.66 ± 0.23 0.44 ± 0.07 0.13 ± 0.01
muscle 1.52 ± 0.17 0.66 ± 0.04 0.34 ± 0.09
pancreas 8.90 ± 0.96 1.08 ± 0.18 0.23 ± 0.07
salivary gland 2.29 ± 0.17 0.30 ± 0.03 0.10 ± 0.02
spleen 2.77 ± 0.14 0.93 ± 0.73 0.17 ± 0.03
thyroid 2.23 ± 0.29 0.51 ± 0.05 0.20 ± 0.03
tumor 2.05 ± 0.48 0.90 ± 0.16 0.42 ± 0.16

The data are expressed as %ID/g with the exception of the thyroid which is expressed as %ID/organ. Error is expressed as standard deviation. n = 3 or 4 for each value.